Department of Infectious Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.
Department of Infectious Diseases, The Affiliated Infectious Diseases Hospital of Soochow University, Suzhou 215000, Jiangsu Province, China.
World J Gastroenterol. 2020 Feb 14;26(6):645-656. doi: 10.3748/wjg.v26.i6.645.
Reports on bacterial infection (BI) in decompensated cirrhosis (DC) is mainly from alcoholic cirrhosis. The role of BI as a trigger or complication of acute-on-chronic liver failure (ACLF) in patients with hepatitis B virus decompensated cirrhosis (HBV-DC) remains to be investigated.
To investigate the impact of BI on the outcomes of the patients with HBV-DC admitted into the hospital with or without ACLF.
This retrospective study included patients with HBV-DC admitted to two tertiary centers in China. In-hospital overall survival, 90-d transplant-free survival, 5-year post-discharge survival, and cumulative incidence of ACLF were evaluated. Risk factors for death were analyzed considering liver transplantation as a competing event.
A total of 1281 hospitalized HBV-DC patients were included; 284 had ACLF at admission. The overall prevalence of BI was 28.1%. The patients with BI had a significantly lower in-hospital survival and transplant-free 90-d survival than those without, in both the patients admitted with and without ACLF. The presence of BI significantly increased the risk of developing ACLF [sub-distribution hazard ratio (sHR) = 2.52, 95%CI: 1.75-3.61, < 0.001] in the patients without ACLF. In the patients discharged alive, those who had an episode of BI had a significantly lower 5-year transplant-free survival. BI was an independent risk factor for death in the patients admitted without ACLF (sHR = 3.28, 95%CI: 1.93-5.57), while in ACLF admissions, the presence of pneumonia, but not other type of BI, independently increased the risk of death (sHR = 1.87, 95%CI: 1.24-2.82).
BI triggers ACLF in patients with HBV-DC and significantly impairs short-term survival. HBV-DC patients should be monitored carefully for the development of BI, especially pneumonia, to avoid an adverse outcome.
关于失代偿期肝硬化(DC)细菌感染(BI)的报告主要来自酒精性肝硬化。乙型肝炎病毒(HBV)失代偿期肝硬化(HBV-DC)患者的 BI 是否作为急性肝衰竭(ACLF)的触发因素或并发症仍有待研究。
探讨 BI 对 HBV-DC 住院患者发生或不发生 ACLF 的结局的影响。
本回顾性研究纳入了中国两家三级中心的 HBV-DC 住院患者。评估了住院期间总生存率、90 天无移植生存率、5 年出院后生存率和 ACLF 的累积发生率。考虑肝移植为竞争事件,分析了死亡的危险因素。
共纳入 1281 例 HBV-DC 住院患者,其中 284 例入院时合并 ACLF。BI 的总患病率为 28.1%。与无 BI 的患者相比,入院时合并或不合并 ACLF 的患者中,有 BI 的患者住院生存率和 90 天无移植生存率均显著降低。在无 ACLF 的患者中,BI 的存在显著增加了发生 ACLF 的风险[亚分布危险比(sHR)=2.52,95%CI:1.75-3.61,<0.001]。在存活出院的患者中,有 BI 发作的患者 5 年无移植生存率显著降低。BI 是无 ACLF 入院患者死亡的独立危险因素(sHR=3.28,95%CI:1.93-5.57),而在 ACLF 入院患者中,肺炎的存在而非其他类型的 BI 独立增加了死亡风险(sHR=1.87,95%CI:1.24-2.82)。
BI 触发 HBV-DC 患者的 ACLF,并显著降低短期生存率。HBV-DC 患者应密切监测 BI 的发生,特别是肺炎,以避免不良结局。